- Home
- KNDI vs PYXS Comparison
KNDI vs PYXS Comparison
Compare KNDI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- PYXS
- Stock Information
- Founded
- KNDI 2002
- PYXS 2018
- Country
- KNDI China
- PYXS United States
- Employees
- KNDI N/A
- PYXS N/A
- Industry
- KNDI Auto Manufacturing
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- PYXS Health Care
- Exchange
- KNDI Nasdaq
- PYXS Nasdaq
- Market Cap
- KNDI 154.6M
- PYXS 124.9M
- IPO Year
- KNDI N/A
- PYXS 2021
- Fundamental
- Price
- KNDI $0.96
- PYXS $1.63
- Analyst Decision
- KNDI
- PYXS Strong Buy
- Analyst Count
- KNDI 0
- PYXS 8
- Target Price
- KNDI N/A
- PYXS $10.00
- AVG Volume (30 Days)
- KNDI 233.9K
- PYXS 2.5M
- Earning Date
- KNDI 11-18-2024
- PYXS 11-12-2024
- Dividend Yield
- KNDI N/A
- PYXS N/A
- EPS Growth
- KNDI N/A
- PYXS N/A
- EPS
- KNDI N/A
- PYXS N/A
- Revenue
- KNDI $118,127,232.00
- PYXS $16,146,000.00
- Revenue This Year
- KNDI N/A
- PYXS N/A
- Revenue Next Year
- KNDI N/A
- PYXS N/A
- P/E Ratio
- KNDI N/A
- PYXS N/A
- Revenue Growth
- KNDI N/A
- PYXS N/A
- 52 Week Low
- KNDI $0.96
- PYXS $1.51
- 52 Week High
- KNDI $3.13
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- KNDI 30.77
- PYXS 32.42
- Support Level
- KNDI $0.97
- PYXS $1.57
- Resistance Level
- KNDI $1.04
- PYXS $1.71
- Average True Range (ATR)
- KNDI 0.07
- PYXS 0.12
- MACD
- KNDI -0.00
- PYXS 0.04
- Stochastic Oscillator
- KNDI 5.00
- PYXS 28.23
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.